Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Nephrology

Hematology/Oncology

Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial

European Journal of Cancer | Dec 04, 2017 Hematology/Oncology

Margin assessment in renal surgery using a handheld optical coherence tomography probe

Urology | Dec 03, 2017 Hematology/Oncology

Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: Exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex

Human Pathology | Nov 30, 2017 Hematology/Oncology

Comparative effectiveness of initial surgery vs initial systemic therapy for metastatic kidney cancer in the targeted therapy era: Analysis of a population-based cohort

Urology | Nov 30, 2017 Hematology/Oncology

PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient's overall survival

Urologic Oncology: Seminars and Original Investigations | Nov 24, 2017 Hematology/Oncology

Diffusion-weighted imaging vs contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas

European Radiology | Nov 23, 2017 Hematology/Oncology

Pathologic and clinical characteristics of early onset renal cell carcinoma

Human Pathology | Nov 16, 2017 Hematology/Oncology

Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)

Urologic Oncology: Seminars and Original Investigations | Nov 15, 2017 Hematology/Oncology

Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma

Urologic Oncology: Seminars and Original Investigations | Nov 12, 2017 Hematology/Oncology

Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era

International Urology and Nephrology | Nov 10, 2017 Hematology/Oncology

« Prev 1 … 21 22 23 24 25 … 29 Next »

Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial

Margin assessment in renal surgery using a handheld optical coherence tomography probe

Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: Exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex

Comparative effectiveness of initial surgery vs initial systemic therapy for metastatic kidney cancer in the targeted therapy era: Analysis of a population-based cohort

PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient's overall survival

Diffusion-weighted imaging vs contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas

Pathologic and clinical characteristics of early onset renal cell carcinoma

Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)

Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma

Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era

The Y Chromosome is Dying: What Does it Means for Men’s Health?

Myxoid Treatment in Alternative Medicine

Recent Advances in Local Anaesthesia

Discussing Weight Issues Sensitively With Your Patients

Managing Obesity: Understanding the Basics

Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial

Margin assessment in renal surgery using a handheld optical coherence tomography probe

Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: Exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex

Comparative effectiveness of initial surgery vs initial systemic therapy for metastatic kidney cancer in the targeted therapy era: Analysis of a population-based cohort

PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient's overall survival

Diffusion-weighted imaging vs contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas

Pathologic and clinical characteristics of early onset renal cell carcinoma

Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)

Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma

Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era

The Y Chromosome is Dying: What Does it Means for Men’s Health?

Myxoid Treatment in Alternative Medicine

Recent Advances in Local Anaesthesia

Discussing Weight Issues Sensitively With Your Patients

Managing Obesity: Understanding the Basics

Select Specialty

Select Topic